Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tritax Big Box secures £550m in new bank loans

(Sharecast News) - Distribution centres investor Tritax Big Box REIT has secured a £550m in new ban loans, refinancing older credit facilities to support the "ongoing delivery of our strategic objectives". The company has entered into a new £400m unsecured revolving credit facility (RCF) over an initial five-year term with a syndicate of 12 lenders, including ABN AMRO, Bank of America and Barclays, refinancing its existing £300m RCF due to mature next June.

The RCF may be extended to a maximum of seven years, and also contains an option to increase the loan by £200m. It has the same margin ratchet as the existing loan, but the interest rate margin will reduce if the company receives a credit rating upgrade in the future from rating agencies Moody's, S&P or Fitch.

The funds will be used for general corporate purposes, as well as to support investment and development activities.

Tritax Big Box also announced a £150m loan with Barclays which matures in October 2027 and can be extended by a further three years, refinancing an existing loan with the same bank. It also contains the same margin reduction mechanism if the company benefits from a rating upgrade.

"The new £400m RCF will increase available liquidity and supports our ongoing ability to execute our strategy, including our attractive logistics and data centre development opportunities whilst maintaining an average cost of debt in line with the level we reported at FY24," said chief financial officer Frankie Whitehead.

"Our strong balance sheet provides us with financial flexibility while our debt maturity profile remains well diversified by both source and by maturity."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.